Alaunos Therapeutics, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Alaunos Therapeutics, Inc. stock issued during period, value, issued for services for the quarter ending 2026-06-30 was $190.00K, a 69.64% increase year-over-year.
- Alaunos Therapeutics, Inc. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $48.00K.
- Alaunos Therapeutics, Inc. stock issued during period, value, issued for services for the quarter ending 2025-12-31 was $46.00K.
- Alaunos Therapeutics, Inc. stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $37.00K.
- Alaunos Therapeutics, Inc. stock issued during period, value, issued for services for fiscal 2025 was $195.00K.
- Alaunos Therapeutics, Inc. stock issued during period, value, issued for services for fiscal 2016 was $87.00K, a 99.87% decline from fiscal 2015.
- Alaunos Therapeutics, Inc. stock issued during period, value, issued for services for fiscal 2015 was $67.28M.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-06-30 | $190.00K 10-Q · filed 2026-08-14 | $321.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $48.00K 10-Q · filed 2026-05-15 | $243.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $195.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $37.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $112.00K 10-Q · filed 2026-08-14 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | $87.00K 10-K · filed 2019-03-05 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $87.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $87.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $87.00K 10-Q · filed 2016-05-10 | $87.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $67.28M 10-K · filed 2018-03-01 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | |
| 2015-03-31 | $67.28M 10-Q · filed 2015-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |